Health care stocks were steady pre-bell Wednesday as the Health Care Select Sector SPDR Fund (XLV) and the iShares Biotechnology ETF (IBB) were flat recently.
Cross Country Healthcare (CCRN) shares surged past 62% after the company and Aya Healthcare announced an agreement under which Aya will acquire Cross Country Healthcare for $18.61 per share in cash for roughly $615 million in transaction value.
Heron Therapeutics (HRTX) shares rose by over 72% after the company said it won a patent dispute over its Cinvanti injectable emulsion against Fresenius Kabi USA.
Novavax (NVAX) shares were up over 2% after the company said it has agreed to sell its manufacturing facility in Bohumil, Czech Republic, to Novo Nordisk (NVO) for $200 million.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。